Position in CRNX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,381,685
+$1,152,147 QoQ
Shares Held
38,042
+671.5% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Derivatives in CRNX
reported options exposure · as of Mar 31, 2026CallValue
$54,480
CallShares
1,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Walleye Capital LLC holds $328,656,270 across 126 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
126,005 | $33,608,053 | |
| 2 | CYTK |
Cytokinetics Inc
|
239,728 | $20,422,428 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
288,233 | $16,492,692 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
386,183 | $14,393,040 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,596 | $14,089,509 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
334,854 | $11,180,775 | |
| 7 | TYRA |
Tyra Biosciences, Inc.
|
347,898 | $11,111,862 | |
| 8 | BCAX |
Bicara Therapeutics Inc.
|
353,226 | $10,487,279 |
All Filings in CRNX
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $54,480 | 1,500 | Call | Sole | 2026-05-13 | |
| 2026-03-31 | $1,381,685 | 38,042 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $229,538 | 4,931 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $5,475,127 | 190,373 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,158,356 | 123,982 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $7,252,176 | 141,838 | Shares | Sole | 2025-02-13 | |
| 2024-12-31 | $219,859 | 4,300 | Call | Sole | 2025-02-13 | |
| 2024-09-30 | $11,290,340 | 220,946 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $219,730 | 4,300 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $1,563,171 | 34,900 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | $14,118,703 | 315,220 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $1,545,255 | 34,500 | Put | Sole | 2024-08-14 | |
| 2024-03-31 | $32,767 | 700 | Put | Sole | 2024-05-15 | |
| 2024-03-31 | $688,107 | 14,700 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $11,298,155 | 241,362 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $9,574,151 | 269,088 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | $78,276 | 2,200 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | $20,818 | 700 | Put | Sole | 2023-11-21 | |
| 2023-09-30 | $12,934,223 | 434,910 | Shares | Sole | 2023-11-21 | |
| 2023-06-30 | $5,651,035 | 313,598 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,965,141 | 433,695 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,421,729 | 405,559 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,910,274 | 250,014 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,873,815 | 154,092 | Shares | Sole | 2022-08-19 | |
| 2022-03-31 | $4,028,768 | 183,543 | Shares | Sole | 2022-05-27 | |
| 2021-12-31 | $2,488,943 | 87,608 | Shares | Sole | 2022-05-27 | |
| 2020-12-31 | $170,731 | 12,100 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||